| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Restructuring and related charges | - | - | 16,400 | - |
| Contingent consideration | - | - | 2,400 | - |
| Foreign exchange transaction losses | - | - | -1,200 | - |
| Asset impairments | - | - | 300 | - |
| Other items | - | - | -300 | - |
| Other expense (income) (note 14) | -6,900 | -5,200 | -20,600 | -4,400 |
| Operating profit | 167,600 | 153,700 | 107,000 | 161,300 |
| Interest expense, net | 200 | 100 | 400 | 700 |
| Interest income | 4,700 | 3,600 | 4,100 | 4,600 |
| Other nonoperating expense (income) | -200 | -200 | -200 | -700 |
| Income before income taxes and equity in net income of affiliated companies | 171,900 | 157,000 | 110,500 | 164,500 |
| Income tax expense | 34,000 | 30,200 | 24,100 | 32,400 |
| Equity in net income of affiliated companies | 2,100 | 5,000 | 3,400 | 3,900 |
| Net income | 140,000 | 131,800 | 89,800 | 136,000 |
| Basic (in dollars per share) | 1.94 | 1.82 | 1.24 | 1.87 |
| Basic (in shares) | 72,200,000 | 72,200,000 | 72,500,000 | 72,800,000 |
| Diluted (in dollars per share) | 1.92 | 1.82 | 1.23 | 1.85 |
| Diluted (in shares) | 72,600,000 | 72,500,000 | 73,000,000 | 73,400,000 |
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)